Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BioNTech News

sk-hynix
Julian Parker 2026 Jul 06, 16:03

Why Is SK Hynix Stock Falling Before Its Nasdaq Listing?

stocks
Darius Anucauskas 2026 Jul 06, 16:03

KOSPI takes a beating, DXY awaits for the next moving data

stocks indices
sliver
Julian Parker 2026 Jul 05, 16:02

Silver Price Forecast: Weak US Jobs Data Lifts XAG/USD, but Risks Remain

commodity
trade
Julian Parker 2026 Jul 01, 16:02

What is a Good P/E Ratio? Formula, Meaning & Trading Guide

cfd trading
vix
Julian Parker 2026 Jun 30, 16:02

What Is the VIX Volatility Index? A Trader’s Guide to Market Fear

cfd trading
micron
Julian Parker 2026 Jun 29, 16:02

Micron (MU) Stock Forecast: 2027, 2030, and 2045 Price Predictions

stocks
Darius Anucauskas 2026 Jun 25, 16:05

Week Ahead: US job data takes the spotlight

commodity forex
Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks

Latest news

Show more
oil
Julian Parker 2026 Jul 06, 16:05

Crude Oil Edges Higher as Projectile Strikes Tanker in the Strait of Hormuz

Commodities
samsung
Julian Parker 2026 Jul 06, 16:04

Samsung Q2 Profit Forecast Surges on AI Chip Demand, but Shares Slide as Investors Take Profit

Stock stocks
gold
Julian Parker 2026 Jul 06, 16:04

Gold Price July 7: Spot Retreats to $4,141 on Firm Dollar

gold price today
spacex
Julian Parker 2026 Jul 06, 16:02

SpaceX Joins Nasdaq-100 as Index Buying Meets Post-IPO Volatility

Stock
gold
Julian Parker 2026 Jul 05, 16:04

Gold Price Today, July 6: Spot Gold Tops $4,174 on US Jobs Data

gold price today
oil
Julian Parker 2026 Jul 05, 16:02

Crude Oil Prices Slip as OPEC+ Boosts Output Targets and Hormuz Traffic Normalises

Commodities
bitcoin
Julian Parker 2026 Jul 05, 16:02

Bitcoin Price Holds Above $63K: Can BTC Extend Its Rebound Toward $65K?

Cryptocurrencies
tsmc-stock
Julian Parker 2026 Jul 05, 16:01

TSMC Stock Nears 52-Week High as Citi Raises Target on Broader AI Chip Demand

Stock

Info

Spread

1.0356

Spread (%)

1.1047 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

24667594752

Shares Outstanding

252884261

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.77

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
stock-split
Julian Parker 2026 Jul 05, 16:02

What Is a Stock Split? Meaning & Examples

gold
Julian Parker 2026 Jul 02, 16:05

Gold Price Forecast & Outlook 2026

gold
Julian Parker 2026 Jul 02, 16:05

Is Gold Trading Halal? An Islamic Guide for Traders

Trustpilot